Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) and Clearmind Medicine (NASDAQ:CMND – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk. Profitability This table compares Esperion Therapeutics and […]
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […]
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) and Clearmind Medicine (NASDAQ:CMND – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings. Analyst Ratings This is a summary of […]
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.50, but opened at $6.27. Prime Medicine shares last traded at $6.12, with a volume of 160,501 shares traded. Wall Street Analysts Forecast Growth Several brokerages recently commented on PRME. Chardan Capital […]
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $6.93, but opened at $7.26. Prime Medicine shares last traded at $6.73, with a volume of 117,359 shares traded. Analysts Set New Price Targets PRME has been the topic of several […]
HC Wainwright assumed coverage on shares of Prime Medicine (NYSE:PRME – Free Report) in a report published on Monday, Marketbeat reports. The firm issued a buy rating and a $10.00 price objective on the stock. HC Wainwright also issued estimates for Prime Medicine’s Q2 2024 earnings at ($0.40) EPS, Q3 2024 earnings at ($0.40) EPS, […]
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Prime Medicine Reports First Quarter 2024 Financial Results And Provides Business Updates menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.